Acceder Registro /

Camilo Julio Llamoza Torres

Buscador

Luque LM, Carlevaro CM, Llamoza Torres CJ, Lomba E. Physics-based tissue simulator to model multicellular systems: A study of liver regeneration and hepatocellular carcinoma recurrence. PLoS Comput Biol. 2023 Mar 6;19(3):e1010920. doi: 10.1371/journal.pcbi.1010920. Online ahead of print. PubMed PMID: 36877741.
AÑO: 2023; IF: 4.3
Re OL, Lopez-Lopez V, Balaguer-Roman A, Martinez-Sanchez MA, Eshmuminov D, Llamoza-Torres CJ, Miura K, Baroja-Mazo A, Ramirez P, Robles-Campos R, Ramos-Molina B. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis. Langenbecks Arch Surg. 2023 Mar 31;408(1):134. doi: 10.1007/s00423-023-02867-8. PubMed PMID: 37000331.
AÑO: 2023; IF: 2.3
Talamantes S, Lisjak M, Gilglioni EH, Llamoza-Torres CJ, Ramos-Molina B, Gurzov EN. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Rep. 2023 Jun 9;5(9):100811. doi: 10.1016/j.jhepr.2023.100811. eCollection 2023 Sep. PubMed PMID: 37575883; PubMed Central PMCID: PMC10413159.
AÑO: 2023; IF: 9.917
Kuchay MS, Martinez-Montoro JI, Llamoza-Torres CJ, Fernandez-Garcia JC, Ramos-Molina B. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022 Oct;11(5):729-731. doi: 10.21037/hbsn-22-355. No abstract available. PubMed PMID: 36268240; PubMed Central PMCID: PMC9577976.
AÑO: 2022; IF: 8.0
Reyes-García R, Rozas-Moreno P, Llamoza-Torres CJ, Mezquita-Raya P. Non-alcoholic fatty liver disease and diabetes. Med Clin (Barc). 2017 Jan 6;148(1):33-38. doi: 10.1016/j.medcli.2016.08.005. Epub 2016 Oct 15. Review. English, Spanish. PubMed PMID: 27751514.
AÑO: 2017; IF: 3.2

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R